Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

AML-associated mutation of nucleophosmin compromises its interaction with nucleolin

M. Šašinková, A. Holoubek, P. Otevřelová, K. Kuželová, B. Brodská,

. 2018 ; 103 (-) : 65-73. [pub] 20180818

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028259

Grantová podpora
NV16-30268A MZ0 CEP - Centrální evidence projektů

C-terminal mutations of the nucleolar protein nucleophosmin (NPM) are the most frequent genetic aberration detected in acute myeloid leukemia (AML) with normal karyotype. The mutations cause aberrant cytoplasmic localization of NPM and lead to loss of functions associated with NPM nucleolar localization, e.g. in ribosome biogenesis or DNA-damage repair. NPM has many interaction partners and some of them were proved to interact also with the mutated form (NPMmut) and due to this interaction thereby to be withdrawn from their site of action. We analyzed the impact of the mutation on NPM interaction with nucleolin (NCL) which is also prevalently localized into the nucleolus and cooperates with wild-type NPM (NPMwt) in many cellular processes. We revealed that the NCL-NPM complex formation is completely abolished by the mutation and that the presence/absence of the interaction is not affected by drugs causing genotoxic stress or differentiation. Deregulation resulting from changes of NCL/NPMwt ratio may contribute to leukemogenesis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028259
003      
CZ-PrNML
005      
20190816131621.0
007      
ta
008      
190813s2018 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.biocel.2018.08.008 $2 doi
035    __
$a (PubMed)30130654
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Šašinková, Markéta $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic.
245    10
$a AML-associated mutation of nucleophosmin compromises its interaction with nucleolin / $c M. Šašinková, A. Holoubek, P. Otevřelová, K. Kuželová, B. Brodská,
520    9_
$a C-terminal mutations of the nucleolar protein nucleophosmin (NPM) are the most frequent genetic aberration detected in acute myeloid leukemia (AML) with normal karyotype. The mutations cause aberrant cytoplasmic localization of NPM and lead to loss of functions associated with NPM nucleolar localization, e.g. in ribosome biogenesis or DNA-damage repair. NPM has many interaction partners and some of them were proved to interact also with the mutated form (NPMmut) and due to this interaction thereby to be withdrawn from their site of action. We analyzed the impact of the mutation on NPM interaction with nucleolin (NCL) which is also prevalently localized into the nucleolus and cooperates with wild-type NPM (NPMwt) in many cellular processes. We revealed that the NCL-NPM complex formation is completely abolished by the mutation and that the presence/absence of the interaction is not affected by drugs causing genotoxic stress or differentiation. Deregulation resulting from changes of NCL/NPMwt ratio may contribute to leukemogenesis.
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a buněčné jadérko $x genetika $x metabolismus $x patologie $7 D002466
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a lidé $7 D006801
650    _2
$a akutní myeloidní leukemie $x genetika $x metabolismus $x patologie $7 D015470
650    _2
$a multiproteinové komplexy $x genetika $x metabolismus $7 D046912
650    12
$a mutace $7 D009154
650    _2
$a nádorové proteiny $x genetika $x metabolismus $7 D009363
650    _2
$a jaderné proteiny $x genetika $x metabolismus $7 D009687
650    _2
$a fosfoproteiny $x genetika $x metabolismus $7 D010750
650    _2
$a proteiny vázající RNA $x genetika $x metabolismus $7 D016601
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Holoubek, Aleš $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic.
700    1_
$a Otevřelová, Petra $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic.
700    1_
$a Kuželová, Kateřina $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic.
700    1_
$a Brodská, Barbora $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic. Electronic address: brodska@uhkt.cz.
773    0_
$w MED00006475 $t The international journal of biochemistry & cell biology $x 1878-5875 $g Roč. 103, č. - (2018), s. 65-73
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30130654 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190816131851 $b ABA008
999    __
$a ok $b bmc $g 1433408 $s 1066719
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 103 $c - $d 65-73 $e 20180818 $i 1878-5875 $m International journal of biochemistry and cell biology $n Int J Biochem Cell Biol $x MED00006475
GRA    __
$a NV16-30268A $p MZ0
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...